Cowen analyst Steve Scala raised the price target on AstraZeneca (NYSE: AZN) to $60.00 (from $55.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE